Highlights
1 patentProfile claimed by owner
About
Novel Drugs Targeting Inflammatory Pathologies
Silkim Pharma has developed a novel, protected platform of drugs for proven treatments of multiple indications. The company's platform is the result of extensive investigation of animal models of human diseases. Members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications.
Identity
| Name | Silkim Pharma |
|---|---|
| Slug | silkim-pharma |
| Type / kind | startup |
| Crunchbase ID | silkim-pharma |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4O60-4kIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ra'anana |
| HQ address | Ranana, Israel |
Web & social
| Website | https://www.silkim.com/ |
|---|---|
| https://www.linkedin.com/company/35704086 | |
| Twitter / X | https://twitter.com/SilkimP |
| https://www.facebook.com/SilkimPharma |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
drug-developmentinflammatory-diseasesdegenerative-diseasestreatmentspharmaceuticalsdrug-discoverycrohn-s-diseasediabetesanti-inflammatory
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}